Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
Condition(s):Attention-Deficit/Hyperactivity DisorderLast Updated:June 28, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Attention-Deficit/Hyperactivity DisorderLast Updated:June 28, 2021Completed
Condition(s):Attention Deficit Disorder With HyperactivityLast Updated:July 30, 2013Completed
Condition(s):Attention-Deficit/Hyperactivity DisorderLast Updated:July 11, 2016Terminated
Condition(s):Attention Deficit Disorder With HyperactivityLast Updated:December 16, 2021Completed
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:February 25, 2016Completed
Condition(s):Attention Deficit Disorder With HyperactivityLast Updated:February 21, 2023Completed
Condition(s):Attention Deficit Hyperactivity DisorderLast Updated:January 13, 2017Completed
Condition(s):Attention Deficit Hyperactivity Disorder (ADHD)Last Updated:January 17, 2018Completed
Condition(s):Attention-Deficit/Hyperactivity DisorderLast Updated:June 8, 2021Completed
Condition(s):Attention-Deficit/Hyperactivity DisorderLast Updated:February 8, 2012Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.